January 2021
-
01.12.2021 Partnerships Finance Investments Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative -
01.10.2021 Partnerships Codex DNA Signs Early Access Collaboration and Licensing Agreement with Pfizer to FurtherDevelop CodexDNA’s Novel Enzymatic DNA Synthesis Technology for Pfizer’s use in its Research and Development ofmRNA-based Vaccines and Biotherapies
December 2020
-
12.07.2020 Corporate Partnerships PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery
November 2020
-
11.19.2020 Partnerships Pfizer and LianBio Announce Strategic Collaboration to Expand Development of Novel Therapeutics in Greater China -
11.09.2020 Partnerships Homology Medicines Announces $60 Million Equity Investment from Pfizer Inc.
October 2020
-
10.05.2020 Partnerships SpringWorks Therapeutics Announces Clinical Collaboration with PfizerInc. to Evaluate Nirogacestat in Combination with PF‐06863135 in Patients with Relapsed or Refractory Multiple Myeloma
September 2020
-
09.23.2020 Partnerships Vivet Therapeutics and Pfizer Inc. Enter into Manufacturing Agreement for Vivet’s Investigational Gene Therapy for Wilson Disease -
09.22.2020 Partnerships Javelin Biotech Aims to Develop Industry-Leading “Organ-on-a-Chip” Predictive Pharmacokinetics Platform in Collaboration with Pfizer Inc.
April 2020
-
04.30.2020 Partnerships AMRA Medical renews collaboration with Pfizer Inc. aiming to generate the world’s largest imaging dataset on body composition profiling -
04.22.2020 Partnerships FoRx Therapeutics AG Raises EUR 10 Million Seed Round to Develop a Pipeline of Drugs Targeting DNA Replication Stress for Cancer -
04.20.2020 Partnerships Valneva Receives FDA Fast Track Designation for its Lyme Disease Vaccine Candidate VLA15
March 2020
-
03.17.2020 Covid-19 Partnerships Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine